BSE Live
Dec 31, 16:00Prev. Close
134.45
Open Price
133.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 31, 15:59Prev. Close
134.45
Open Price
134.00
Bid Price (Qty.)
134.45 (41)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Sun Pharma Advanced Research Company (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 3 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -21.54 | -12.49 | -4.56 | -1.83 | 0.00 | |
| Net CashFlow From Operating Activities | 12.63 | 25.45 | -20.39 | -0.04 | 0.00 | |
| Net Cash Used In Investing Activities | -12.17 | -26.09 | 20.08 | 0.00 | 0.00 | |
| Net Cash Used From Financing Activities | 0.28 | 1.05 | -0.01 | 0.00 | 0.05 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.75 | 0.41 | -0.33 | -0.04 | 0.05 | |
| Cash And Cash Equivalents Begin of Year | 0.52 | 0.11 | 0.01 | 0.05 | 0.00 | |
| Cash And Cash Equivalents End Of Year | 1.27 | 0.52 | -0.32 | 0.01 | 0.05 |
17.11.2025
Sun Pharma Adv Consolidated September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.11.2025
Sun Pharma Adv Standalone September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
17.11.2025
Sun Pharma Adv Consolidated September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.11.2025
Sun Pharma Adv Standalone September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y